Clinical Trial

WATER IV PCa (AS Sub-study)

Name: WATER IV PCa (AS Sub-study) — clinical trial record (NCT07650448)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The WATER IV study is a multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate cancer.

Protocol Amendment History 2 changes

notable Trial sites expanded: 17 -> 25 locations 2026-08-05

notable Trial sites expanded: 0 -> 17 locations 2026-06-24

Trial Details

NCT Number	NCT07650448
Lead Sponsor	PROCEPT BioRobotics
Conditions	Localized Prostate Cancer
Enrollment	333 participants
Start Date	2026-09
Primary Completion	2028-12 (estimated)
Study Completion	2038-12 (estimated)
Updated on ClinicalTrials.gov	2026-08-04